4th Pediatric Infectious Diseases Conference
 
 
Home  Back   ISSN 0973 - 0958
 
User name :
Password :
Follow Us : Follow On Facebook Follow On Twitter Follow On Youtube
Specialist Answers
Question
One and half year male ATHARVA had Miliary koch's with Hepatosplenomegaly. He was born Preterm VLBW Gest age 32-34 wks (800 Grs.)& was getting recurrent resp. tract infections. His previous X rays were normal. For last Nine months he was on 4 drugs AKT (SHRZ)for 2 months & then 3 drugs AKT(HRZ)for last 4 months along with Oral Ofloxacin. He developed severe abdominal pain. H-S megaly is persistent. No urinary/ bowel complaints. Urine routine NAD. Deworming done, USG showing H-S megaly. No other positive findings. X ray chest shows still miliary shadows. Query (1) What could be the cause of his Abdominal Pain? (2) What modifications in the AKT will control is Miliary TB?
Answer
Rule out other infections such as HIV, fungal infections. Since the miliary shadows are persisting, rule out interstitial lung disease. Since miliary shadows may be seen with lot of other conditions, even histiocytosis must be rule out. A lung biopsy may be needed.
 
 
 
Pedi Poll
Today's Poll
Should teicoplannin, colistin be used in case of neonatal sepsis where culture does not reveal any organism_?
No, it should be used only after drug sensitivity report
Yes, under guidance of an infectious disease expert
Educational Section
 
Disclaimer:
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
 
copyright ©2011 website design & development by Levioza
Follow Us
Follow us on :
Folllow Us